Earnings Alerts

Exploring the Surge in Taiwan Cement (1101) Earnings: April Sales Reveal a 27.8% Increase

  • Taiwan Cement‘s sales for April stand at NT$11.63B.
  • There has been a significant increase in sales with a rise of 27.8%.
  • The market response to Taiwan Cement‘s performance has been mixed – with 3 buys, 5 holds, and 1 sell.

A look at Taiwan Cement Smart Scores

FactorScoreMagnitude
Value5
Dividend2
Growth2
Resilience3
Momentum3
OVERALL SMART SCORE3.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Analysts at Smartkarma have provided an insightful overview of Taiwan Cement Corporation’s performance, highlighting its strong value proposition with an impressive score of 5 in the Value category. This suggests that Taiwan Cement is considered to be fundamentally undervalued based on various financial metrics. Additionally, the company has achieved moderate scores in Resilience and Momentum, indicating a stable and consistent performance over time. However, Taiwan Cement lags behind in Dividend and Growth scores, reflecting potential areas for improvement in terms of returning profits to shareholders and expanding its business.

Taiwan Cement Corporation, a leading manufacturer of cement products, has a promising long-term outlook according to the Smartkarma Smart Scores. While excelling in value creation, the company is encouraged to focus on enhancing its dividend distribution and fostering growth opportunities. With a diversified product range including high strength cement and specialized agents, Taiwan Cement extends its operations beyond traditional manufacturing to encompass transportation, construction, and information products businesses, further solidifying its position in the market.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars